Landmark Hospitals Compassionate Use Study for Critical COVID-19 Patients Evidences Potential for Allogenic Biologic Product

Landmark Hospitals Compassionate Use Study for Critical COVID-19 Patients Evidences Potential for Allogenic Biologic Product

Landmark Hospital manages six long-term acute care hospitals across the Southeast United States and recently announced its decision to offer an investigational allogenic biologic product derived from amniotic fluid to patients with advanced COVID-19 conditions under...
Cincinnati Children’s Investigator Idea May Lead to Answer to COVID-19 Deadly Cytokine Storm: Ruxolitinib

Cincinnati Children’s Investigator Idea May Lead to Answer to COVID-19 Deadly Cytokine Storm: Ruxolitinib

Cincinnati Children’s researchers initially developed a transgenic mouse to model HLH (hemophagocytic lymphohistiocytosis), a deadly childhood immune disease but as it now turns out this effort may end up saving lives during the COVID-19 pandemic. Cincinnati...
HHMI-backed Johns Hopkins Hosted Team Investigates Use of Alpha Blockers (Prazosin) to Combat a Deadly COVID-19 Condition: Cytokine Storm

HHMI-backed Johns Hopkins Hosted Team Investigates Use of Alpha Blockers (Prazosin) to Combat a Deadly COVID-19 Condition: Cytokine Storm

Although considered eccentric toward the end, Howard Hughes was incredibly rich and put that capital to work in many interesting and important ways, including what has become one of the largest private funding organizations for biological medical research in the...
B.C. Research Focuses on Managing Immune Response in Critically ill COVID-19 Patients

B.C. Research Focuses on Managing Immune Response in Critically ill COVID-19 Patients

British Columbia (B.C.) physicians and scientists are learning more about the links between the body’s immune system and the new coronavirus after the recovery of a 32-year-old who nearly died from acute COVID-19. Physicians and researchers at Vancouver General...

Pin It on Pinterest